CClinicalTrials.gg
CompletedNCT05427773BionicUpdated Feb 3, 2023

(In)Voluntary Assessed Quadriceps Muscle Endurance in COPD

An observational study in Pulmonary Disease, Chronic Obstructive, sponsored by Radboud University Medical Center. Completed at 1 site in Netherlands. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-02-03.

Sponsored by Radboud University Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
26
Ages
40 Years to 80 Years
Sex
All
01

Study summary

The primary objective is to assess the relation between involuntary and voluntary assessed quadriceps muscle endurance in patients with COPD. We hypothesized a good correlation (>0.8) between the measurements.

Read the detailed description

Rationale: Quadriceps muscle endurance is reduced in patients with COPD. However, no consensus has been reached yet on the best method to evaluate quadriceps muscle endurance. One important aspect is the large variety in protocols and devices used around the world. Commonly used and reliable measures are voluntary protocols performed on a computerized dynamometer. However, these voluntary measurements might also be influenced by external factors as patients effort or motivation. Therefore, it is important to evaluate the relation between voluntary and involuntary (i.e. electrical stimulated) assessed quadriceps muscle endurance.

Objective(s): The primary objective is to assess the relation between involuntary and voluntary assessed quadriceps muscle endurance in patients with COPD.

Study design: Cross-sectional observation study.

Study population: 20 COPD patients who perform baseline assessment at the pulmonary rehabilitation centre at Radboudumc (Nijmegen, the Netherlands).

Intervention: not applicable

Main study parameters/endpoints: The primary outcome will be the electrically evoked isometric quadriceps muscle endurance (fatigue resistance) and voluntary isokinetic (work fatigue index5) and isometric quadriceps endurance (time).

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: BURDEN: All measurements are part of standard care, except for one questionnaire and (involuntary) electrical assessed quadriceps function. Thus, the additional burden for the patient is one additional measurement of approximately 70 minutes. RISKS: Performance of electrically evoked assessment of muscle function is not associated with a health risk. This procedure is non-invasive and not painful and performed routinely at the department of Physiology (Radboudumc, Nijmegen). Therefore, no safety risk is involved.

BENEFIT: The benefits will be high as it will provide more insight in the relation between voluntary and involuntary assessed quadriceps muscle endurance. This insight is necessary to optimize the clinical assessment of muscle endurance in patients with COPD.

GROUP RELATEDNESS: This will be the first study in which the relation between voluntary and involuntary assessed quadriceps muscle endurance in COPD will be investigated. These results will also be valuable for other diseases/conditions in which isolated muscle endurance should be assessed like asthma, pulmonary hypertension, etc.

02

Conditions studied

  • Pulmonary Disease, Chronic Obstructive

Keywords

  • Peripheral muscle endurance
  • Electrical stimulation
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 26 is below the median of 157 across 929 observational studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with COPD that start with the pulmonary rehabilitation program at the Radboudumc in Nijmegen.

Inclusion criteria

  • COPD, based on GOLD classification
  • Clinically stable according to the pulmonary physician, i.e. no exacerbation and/or hospitalization within the previous 4 weeks
  • Age between 40-80 years
  • Take part in the pulmonary rehabilitation program at Radboudumc (Nijmegen)

Exclusion criteria

Exclusion Criteria:

  • Inability to understand the Dutch language
  • Musculoskeletal and neurological problems influencing quadriceps muscle function testing
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
26 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Electrically evoked fatigue resistance (%)

    Fatigue resistance (%) is the decline in muscle force generated using electrical stimulation.

    Time frame: Performed in first week of pulmonary rehabilitation program

  2. Voluntary isometric quadriceps endurance (time to fatigue).

    Voluntary isometric quadriceps endurance (time to fatigue in seconds) is determined on the computerized dynamometer. The isometric endurance test protocol is performed by asking participants to maintain, for as long as possible, an isometric quadriceps contraction representing 60% of the individual isometric maximal voluntary contraction (MVC) force. The test will be ended if the force of the contraction was less than 50% of the MVC for three consecutive seconds.

    Time frame: Performed in first week of pulmonary rehabilitation program

  3. Voluntary isokinetic work fatigue index.

    Voluntary isokinetic work fatigue (%) is the decline in work over 30 repetitions determined on the computerized dynamometer. The isokinetic protocol consists of 30 contractions at an angular velocity of 90°/s with maximal effort during extension and passive (submaximal) flexion. Work fatigue index = \*work first 5 repetitions - work last 5 repetitions) / work first 5 repetitions \* 100%

    Time frame: Performed in first week of pulmonary rehabilitation program

07

Study locations

1 site
  • Radboudumc
    Nijmegen, Gelderland 6525 GA, Netherlands
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05427773
Lead sponsor
Radboud University Medical Center
Responsible party
Sponsor
First posted
Jun 22, 2022
Start date
Jul 5, 2022
Primary completion
Jan 20, 2023
Completion
Jan 20, 2023
Last update
Feb 3, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion